From: Incidence of thyroid cancer in Puerto Rico and the US by racial/ethnic group, 2011–2015
Age-adjusted rate | SRR (95% CI) | ||||||
---|---|---|---|---|---|---|---|
PR | NHW | USH | NHB | PR vs NHWa | PR vs USHa | PR vs NHBa | |
Women | 40.0 | 21.8 | 17.8 | 11.6 | 1.83 (1.77–1.90) | 2.25 (2.17–2.34) | 3.45 (3.29–3.62) |
< 20 | 2.9 | 1.9 | 1.5 | 0.5 | 1.51 (1.16–1.92) | 1.92 (1.46–2.47) | 5.79 (3.97–8.63) |
20–39 | 38.0 | 25.5 | 17.6 | 9.3 | 1.49 (1.39–1.60) | 2.17 (2.00–2.34) | 4.08 (3.69–4.52) |
40–59 | 75.5 | 37.1 | 30.7 | 21.2 | 2.03 (1.93–2.13) | 2.45 (2.32–2.60) | 3.56 (3.33–3.81) |
60–79 | 59.8 | 28.8 | 29.0 | 22.2 | 2.08 (1.95–2.21) | 2.06 (1.90–2.24) | 2.69 (2.46–2.95) |
80+ | 16.1 | 10.2 | 11.8 | 8.2 | 1.58 (1.21–2.00) | 1.37 (1.00–1.85) | 1.95 (1.38–2.78) |
Men | 9.8 | 7.3 | 4.5 | 3.1 | 1.34 (1.25–1.44) | 2.19 (2.01–2.38) | 3.22 (2.90–3.57) |
< 20 | 0.5 | 0.4 | 0.3 | 0.1 | 1.45 (0.75–2.39) | 1.72 (0.88–2.94) | 5.17 (2.25–13.31) |
20–39 | 7.7 | 5.7 | 2.8 | 1.4 | 1.35 (1.15–1.58) | 2.71 (2.25–3.22) | 5.37 (4.17–6.98) |
40–59 | 16.9 | 11.9 | 6.8 | 4.9 | 1.42 (1.27–1.58) | 2.50 (2.20–2.83) | 3.43 (2.95–3.99) |
60–79 | 20.7 | 16.1 | 11.5 | 8.5 | 1.29 (1.14–1.44) | 1.80 (1.55–2.09) | 2.42 (2.04–2.89) |
80+ | 8.5 | 9.3 | 8.7 | 5.5 | 0.91 (0.58–1.32) | 0.98 (0.58–1.57) | 1.55 (0.86–2.84) |